C
072020
vs
K
KOSPI 200
Over the past 12 months, Choong Ang Vaccine Laboratory has underperformed KOSPI 200, delivering a return of -5% compared to KOSPI 200's +148% growth.
Stocks Performance
072020 vs KOSPI 200
Performance Gap
072020 vs KOSPI 200
Performance By Year
072020 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Choong Ang Vaccine Laboratory
Glance View
Choong Ang Vaccine Laboratory makes vaccines and related biological products for animals. Its business is centered on animal health, especially medicines used to prevent disease in livestock and other farm animals. The company sells these products to veterinarians, farms, distributors, and other animal-health buyers that need reliable disease prevention tools. The company earns money by manufacturing and selling veterinary vaccines and other animal-health products. In this business, the main value is not treating animals after they get sick, but helping customers prevent outbreaks in the first place. That makes the company part of the preventive side of the livestock supply chain, where product quality, safety, and disease control matter a lot. What makes this kind of business different is that it depends on scientific know-how, regulatory approval, and trust from animal-health professionals. Unlike general drug makers, a vaccine laboratory in this field must develop products that match specific animal diseases and farming needs. Its role is specialized: it helps protect animal herds, support food production, and reduce losses from disease.
